Open main menu
Search Ctrl + K
Free Trial
Loading...
Teva Pharmaceutical Industries Ltd
Watch
Pharmaceutical Preparations
NYSE.TEVA
5 Bazel St, P O B 3190, Petach Tikva, L3, 49131
Categorized
Chronological
Ownership by Owner
Insider Transactions
Institutional Owners
Filings by Form Type
Transcripts
Your Highlights
Search Within Documents
Key Exhibits
Articles & Bylaws
Indentures
Material contracts
Plans of Reorganization
Underwriting Agreements
External Links
Google Finance
SEC EDGAR
Loading...
Loading...
Latest Filings – Ownership
4
Fox Christine
21 Nov 24
144
Fox Christine
20 Nov 24
SC 13G
12 Nov 24
4
Shalev Varda
04 Sep 24
144/A
Hughes Eric A
14 Aug 24
144/A
Daniell Richard
14 Aug 24
4
Hughes Eric A
13 Aug 24
4
Grant Angus
13 Aug 24
4
Daniell Richard
13 Aug 24
144
Hughes Eric A
12 Aug 24
144
Daniell Richard
12 Aug 24
144
Grant Angus
09 Aug 24
4
Hughes Eric A
05 Aug 24
4
Jover Placid
05 Aug 24
3
Jover Placid
05 Aug 24
144
Hughes Eric A
01 Aug 24
4
Mignone Roberto
21 Jun 24
144
Bridger Management, Llc (1)
18 Jun 24
4
Nisen Perry
17 Jun 24
4
Lieberman Gerald M
17 Jun 24
Latest Filings – Non-Ownership
8-K
Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers: Compensatory Arrangements Of Certain Officers
12 Nov 24
10-Q
Quarterly Filing
06 Nov 24
8-K
Results Of Operations And Financial Condition, Financial Statements And Exhibits
06 Nov 24
8-K
Results Of Operations And Financial Condition, Financial Statements And Exhibits
31 Jul 24
10-Q
Quarterly Filing
31 Jul 24
8-K
Entry Into A Material Definitive Agreement
25 Jun 24
8-K
Submission Of Matters To A Vote Of Security Holders
06 Jun 24
SD
Specialized Disclosure Report Related To Conflict Minerals.
30 May 24
8-K
Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers: Compensatory Arrangements Of Certain Officers, Regulation Fd Disclosure, Financial Statements And Exhibits
15 May 24
8-K
Results Of Operations And Financial Condition, Financial Statements And Exhibits
08 May 24
10-Q
Quarterly Filing
08 May 24
8-K
Regulation Fd Disclosure, Financial Statements And Exhibits
18 Apr 24
ARS
Scanned Paper Annual Report Submission.
16 Apr 24
DEFA14A
Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.
16 Apr 24
DEF 14A
Definitive Proxy Statement Provided In Advance Of A Shareholder Meeting.
16 Apr 24
10-K
Fiscal Year 2023
12 Feb 24
8-K
Results Of Operations And Financial Condition, Financial Statements And Exhibits
31 Jan 24
10-Q
Quarterly Filing
09 Nov 23
8-K
Results Of Operations And Financial Condition, Financial Statements And Exhibits
08 Nov 23
8-K
Regulation Fd Disclosure, Financial Statements And Exhibits
04 Oct 23